Stay updated on Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Sign up to get notified when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.

Latest updates to the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision tag in the footer was updated from v3.6.4 to v3.6.5, signaling a new deployment/iteration of the site.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision indicator updated from v3.6.3 to v3.6.4, signaling a new build of the page. This is a metadata version update and does not modify the displayed content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe revision label on the page updated from v3.6.2 to v3.6.3, reflecting a small software update to the site.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision banner updated from v3.6.0 to v3.6.2, reflecting a small backend/template update rather than changes to the study details displayed on the page.SummaryDifference0.1%

- Check58 days agoChange DetectedRecruitment status now indicates the study is not enrolling, and the page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) while adjusting the Intervention/Treatment label and including a revision note.SummaryDifference0.9%

- Check65 days agoChange DetectedRevision label on the study record updated from v3.5.4 to v3.5.5. This represents a minor metadata update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.